In 2024, the market was valued at approximately USD 1.1 billion, reflecting a combination of expanding pediatric care initiatives, innovation in growth hormone therapies, and rising parental awareness. With ongoing research and increasing adoption of advanced therapies, the market is projected to maintain a steady growth trajectory over the forecast period.